Covestor
TRVI icon

Covestor’s Trevi Therapeutics TRVI Stock Holding History

Covestor’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
19
-24
-56% -$413 ﹤0.01% 2838
2026
Q2 		$1K Buy
43
+31
+258% +$451 ﹤0.01% 2355
2026
Q1 		$0 Buy
+12
New +$134 ﹤0.01% 2776

Other funds holding TRVI

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.25B AUM 28.18% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
PFS Partners
PFS Partners Mine Hill, New Jersey $246M AUM 22.61% 1-Year Est. Return
Harbour Capital Advisors
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Chapin Davis
Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Covestor's TRVI Position: Q3 2026 in Review

Covestor reduced its Trevi Therapeutics (TRVI) stake by 56% in Q3 2026, selling an estimated $413 and leaving 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

Covestor first reported a position in TRVI in Q1 2026 and has held it in 3 quarters since. The position peaked at $1K in Q2 2026. 36 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Covestor held 19 shares of Trevi Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 24 Trevi Therapeutics shares in Q3 2026, an estimated $413.
  • Trevi Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2838 holding.
  • Covestor first reported a position in Trevi Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Covestor's Trevi Therapeutics position peaked at $1K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.